Awakn Life Sciences Corp. announced a non-brokered private placement for issuance of 2,173,913 units at a price of CAD 0.46 per unit for gross proceeds of up to CAD 999,999.98 on April 3, 2024. Each unit is comprised of one common share and three quarters of one whole common share purchase warrant.

Each warrant entitles the holder thereof to acquire one common share at a price of CAD 0.63 per common share for a period of five years from the date of issuance. The closing of the offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of CSE Exchange. All securities issued in connection with the offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.